Supernus share price logo

Supernus

NSQ: SUPN

Small Cap

$27.21

-1.00

(-3.53%)

Live

as on

Supernus Stock Performance

as on November 6, 2026 at 4:46 am IST

  • Day's Low

    Day's High

    $27.13
    $28.79
    downward going graph

    0.29%

    Downside

    5.81%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $26.74
    $59.68
    downward going graph

    1.73%

    Downside

    119.33%

    Upside

    downward going graph

Supernus share price movements today

Previous Close
$28.21
Open
$28.27
Volume
1.9M
Market Cap
$1.6B
Dividend Yield
28.88%
Day's Low - High
$27.13 - $28.79
52 Week Low - High
$26.74 - $59.68

Supernus Historical Returns

1 Month Return
-34.03 %
3 Month Return
-39.86 %
1 Year Return
-40.12 %
3 Year Return
+ 15.24 %
5 Year Return
-12.39 %

Supernus Stock Fundamentals & Key Indicators

Check Supernus market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.6B

EPS (TTM)

3.66

Dividend Yield

28.88%

Quarterly Earnings Growth YOY

0.11%

PE Ratio (TTM)

7.69

Industry PE ratio

-1.03

PEG Ratio

0.04

EBITDA

568.0M

Revenue (TTM)

1.4B

Profit Margin

85.15%

Return On Equity TTM

-352.94%

Supernus vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Supernus with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$1.6B-12.39%7.6985.15%28.88%
Buy$44.7BNA68.1547.54%1.02%
StrongBuy$25.8B200.79%19.8986.14%0.00%
Buy$21.5B40.60%-52.0034.83%2.56%
Buy$38.2BNA17.9565.57%1.40%

Stock Returns calculator for Supernus Stock including INR - Dollar returns

The Supernus stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Supernus investment value today

Current value as on today

₹61,618

Returns

-₹38,382

(-38.38%)

Returns from Supernus Stock

-₹42,242 (-42.24%)

Dollar Impact

₹3,860 (+3.86%)

Analyst Recommendation on Supernus Stock

Based on 2 analysts

BUY

50.00%

Buy

50.00%

Hold

0.00%

Sell

Based on 2 analysts, 50% of analysts recommend a 'BUY' rating for Supernus. Average target price of $60.5

Supernus Share Price Target

Get share price movements and forecasts by analysts on Supernus.

What analysts predicted

55.02%UPSIDE

Target Price

$60.5

Current Price

$27.21

Analyzed by

2 Analysts

High

$87

Target

$60.50

Low

$37

Supernus target price $60.5, a slight upside of 55.02% compared to current price of $27.21. According to 2 analysts rating.

Supernus Quarterly Profit & Loss

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Total Revenue
299
307
299
266
302
314
358
316
343
356
Gross Profit
220
238
276
222
250
252
294
276
294
305
Operating Income
-118
4
96
66
72
99
122
137
160
181
EBITDA
-106
17
106
76
82
54
92
125
165
185
Interest Expense
9
10
13
12
15
12
6
6
2
2
Depreciation
6
8
5
5
5
5
5
4
3
1
Income Before Tax
-121
-1
88
59
62
37
81
115
160
182
Income Tax Expense
-23
-5
28
11
44
-5
-21
25
38
45
Net Income
-97
4
59
47
18
42
102
88
122
137
Net Profit Margin
89.36%
89.99%
85.01%
89.48%
82.78%
80.25%
82.12%
87.38%
85.71%
85.67%

Supernus Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
1,148
959
785
647
791
901
1,093
1,188
1,239
Gross Profit
1,025
825
645
550
664
750
919
957
993
Operating Income
423
317
178
-156
213
-81
-156
32
265
EBITDA
206
311
230
-123
238
-46
-99
83
304
Interest Expense
49
31
22
24
26
29
35
41
45
Depreciation
13
16
28
26
22
16
15
28
20
Income Before Tax
143
265
180
-173
190
-89
-149
14
239
Income Tax Expense
82
2
46
-25
-15
-44
-20
11
29
Net Income
60
262
134
-148
205
-44
-129
2
210
Net Profit Margin
94.97%
96.24%
95.76%
89.92%
87.05%
86.93%
86.21%
88.23%
80.15%

Supernus Quarterly Cash Flow

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Net Income
-97
22
66
47
18
43
102
89
122
137
Operating Cash Flow
88
2
-5
75
158
-39
-221
-9
229
97
Investing Cash Flow
1
35
10
-5
-17
-20
-24
-19
-8
-14
Financing Cash Flow
-35
-51
27
-17
-5
-3
-5
7
-173
0
Change in Cash
54
-14
31
53
137
-64
-250
-20
48
83

Supernus Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
193
292
178
-156
213
-44
-126
7
210
Operating Cash Flow
295
303
151
-193
353
-4
-300
36
-27
Investing Cash Flow
-43
-4
-2
-4
-14
-222
-95
69
-66
Financing Cash Flow
-84
-237
-13
-10
-94
-101
-64
-102
-30
Change in Cash
171
61
136
-202
244
-328
-458
3
-124

Global Institutional Holdings in Supernus

Check out the Institutions with significant holdings in Supernus.

Funds
Holdings
BlackRock, Inc.
15.85%
iShares
11.60%
Vanguard
9.47%
VANGUARD INDEX FUNDS
8.20%
Capitol Series Trust
2.87%

Supernus News & Key Events

    Insights on Supernus

    Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

    • imgPOSITIVE IMPACT

      Revenue Rich

      img

      Revenue is up for the last 3 quarters, 207.70M → 226.77M (in $), with an average increase of 4.3% per quarter

    • imgPOSITIVE IMPACT

      Profit Spike

      img

      Netprofit is up for the last 2 quarters, -58.37M → 20.91M (in $), with an average increase of 379.1% per quarter

    • imgNO EFFECT

      Against Peers

      img

      In the last 1 year, Viatris Inc. Common Stock has given 78.8% return, outperforming this stock by 118.9%

    • imgNO EFFECT

      Against Peers

      img

      In the last 3 years, SANDOZ GROUP AG SPONSORED ADS Switzerland has given 107.3% return, outperforming this stock by 92.1%

    • imgNEGATIVE IMPACT

      Price Dip

      img

      In the last 7 days, SUPN stock has moved down by -32.6%

    About Supernus

    Supernus, Inc. is a diversified biopharmaceutical company focused on developing and commercializing treatments for central nervous system (CNS) diseases. Its portfolio of 11 marketed products spans opioid use disorder, psychiatry, and neurology, and includes SUBLOCADE, a long-acting injectable buprenorphine for opioid use disorder, along with sublingual OUD treatments; Qelbree, a non-stimulant treatment for attention-deficit hyperactivity disorder (ADHD); GOCOVRI for dyskinesia in Parkinson’s disease patients receiving levodopa-based therapy; ONAPGO for motor fluctuations in advanced Parkinson’s disease; ZURZUVAE for postpartum depression; and treatments for epilepsy, migraine, cervical dystonia, and chronic sialorrhea, including Oxtellar XR, Trokendi XR, APOKYN, and MYOBLOC. The company also advances a pipeline of novel CNS product candidates. Its products are sold primarily in the United States, with additional markets including Canada, Australia, France, and Germany. The company was formed through the November 2026 merger of Supernus Pharmaceuticals, Inc. and Indivior Pharmaceuticals, Inc., and is headquartered in Rockville, Maryland.
    OrganisationSupernus
    Headquarters9715 Key West Avenue, Rockville, MD, 20850, US
    IndustryDrug Manufacturers - Specialty & Generic
    CEOJack A. Khattar

    Key Management of Supernus

    Name

    Title

    Mr. Jack A. Khattar M.B.A.

    Founder, President, CEO, Secretary & Director

    Mr. Timothy C. Dec

    Senior VP & CFO

    Mr. Taylor Raiford

    Senior Vice President of Sales

    Dr. William Todd Horich M.B.A., Ph.D.

    Senior VP & Chief Commercial Officer

    Dr. Bryan A. Roecklein Ph.D.

    Senior VP & Chief Business Officer

    Mr. Jeff Bozick

    Senior Vice President of Supply Chain

    Dr. Padmanabh P. Bhatt Ph.D.

    Chief Scientific Officer & Senior VP of Intellectual Property

    Mr. Frank Mottola

    Senior VP & Chief Technology Operations Officer

    Dr. Jonathan Rubin M.B.A., M.D.

    Senior VP of Research & Development and Chief Medical Officer

    FAQs

    What is Supernus share price today?

    Supernus share price today is $27.21 as on . Supernus share today touched a day high of $28.79 and a low of $27.13.

    What is the 52 week high and 52 week low for Supernus share?

    Supernus share touched a 52 week high of $59.68 on and a 52 week low of $26.74 on . Supernus stock price today i.e. is trending at $27.21,which is 54.41% down from its 52 week high and 1.76% up from its 52 week low.

    What is Supernus's market capitalisation today?

    Supernus market capitalisation is $0.00T as on .

    How to invest in Supernus Stock (SUPN) from India?

    1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
    2. Step 2: Search for Supernus on INDmoney app. Click on Buy button.

    What is the minimum amount required to buy Supernus Stock (SUPN) from India?

    Indian investors can start investing in Supernus (SUPN) shares with as little as ₹94.4749984741211 or $1 (as of ) using the INDmoney app.
    For example: If you want to invest $10 or ₹944.75 in Supernus stock (as per the Rupee-Dollar exchange rate as on ). Based on Supernus share’s latest price of $27.21 as on November 5, 2026 at 11:16 pm IST, you will get 0.3675 shares of Supernus. Learn more about fractional shares .

    What are the returns that Supernus has given to Indian investors in the last 5 years?

    Supernus stock has given -12.39% share price returns and 27.92% dollar appreciation to an Indian investor in the last 5 years.
    Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?